Skip to main content

Exact Sciences to Participate in May Investor Conference

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

  • BofA Securities Health Care Conference, Las Vegas

    Fireside chat on Wednesday, May 14, 2025 at 1:40 p.m. ET (10:40 a.m. PT)

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.54
-3.65 (-1.61%)
AAPL  274.11
-4.17 (-1.50%)
AMD  207.58
-3.20 (-1.52%)
BAC  55.33
+0.19 (0.34%)
GOOG  309.32
-1.20 (-0.39%)
META  647.51
+3.28 (0.51%)
MSFT  474.82
-3.71 (-0.78%)
NVDA  176.29
+1.27 (0.73%)
ORCL  184.92
-5.05 (-2.66%)
TSLA  475.31
+16.35 (3.56%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.